ASCO 2023
2-6 June 2023, McCormick Place, Booth # 4113, Chicago, IL
The most comprehensive span of Oncology clinical development services — delivered seamlessly
With a singular focus on clinical research and commercialisation, we’re committed to achieving clients’ clinical development programmes across the entire product lifecycle.
ICON’s comprehensive suite of clinical development services are flexible and fully customisable. Regardless of your company’s size, we work your way to deliver better outcomes.
Meet our experts at ASCO, Booth #4113 to learn about ICON’s full suite of services to support your Oncology clinical development programme.
- Oncology Drug Development Consultancy Services
- Early Phase Oncology
- Feasibility, Site & Patient Recruitment, Site Networks
- Centre for Cell & Gene Therapy
- Centre for Paediatric Clinical Development
- Decentralised Clinical Trials, including In-Home Services
- Central, Bioanalytical and Specialty Laboratories
- Medical Imaging
- Global Regulatory Consulting
-
Real World Data Intelligence and Commercialisation & Outcomes
Meet our Experts
Andreas Dreps, Ph.D.
SVP, Drug Development Services
Martin Lachs, Ph.D.
VP, Project Management, Oncology & Cell Therapeutics
Jim Wise, MS
VP, Head of Centre for Cell & Gene Therapy
Brian Huber, Ph.D.
VP, Drug Development Solutions
Tanja Obradovic, Ph.D.
Vice President, Scientific Affairs
Paul McCracken, Ph.D.
VP, Global Head of Medical Imaging
Meet Our Experts
Submit our short form to request a meeting with one of our experts